Global Molnupiravir Market Growth 2024-2030

Publication ID:

LPI12241175

Publication Date:

December 17, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Molnupiravir market size was valued at US$ 44 million in 2023. With growing demand in downstream market, the Molnupiravir is forecast to a readjusted size of US$ 70 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Molnupiravir market. Molnupiravir are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molnupiravir. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molnupiravir market.
Molnupiravir is a small-molecule ribonucleoside prodrug of N-hydroxycytidine (NHC), which has activity against SARS-CoV-2 and other RNA viruses and a high barrier to development of resistance.
Key Features:
The report on Molnupiravir market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Molnupiravir market. It may include historical data, market segmentation by Type (e.g., Patented Drug, Generic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molnupiravir market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Molnupiravir market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Molnupiravir industry. This include advancements in Molnupiravir technology, Molnupiravir new entrants, Molnupiravir new investment, and other innovations that are shaping the future of Molnupiravir.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molnupiravir market. It includes factors influencing customer ' purchasing decisions, preferences for Molnupiravir product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molnupiravir market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molnupiravir market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molnupiravir market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molnupiravir industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molnupiravir market.
Market Segmentation:
Molnupiravir market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Patented Drug
Generic Drug
Segmentation by application
Antiviral Drug
COVID-19
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Optimus Pharma
Sun Pharma
Beximco
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molnupiravir market?
What factors are driving Molnupiravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molnupiravir market opportunities vary by end market size?
How does Molnupiravir break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molnupiravir Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Molnupiravir by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Molnupiravir by Country/Region, 2019, 2023 & 2030
2.2 Molnupiravir Segment by Type
2.2.1 Patented Drug
2.2.2 Generic Drug
2.3 Molnupiravir Sales by Type
2.3.1 Global Molnupiravir Sales Market Share by Type (2019-2024)
2.3.2 Global Molnupiravir Revenue and Market Share by Type (2019-2024)
2.3.3 Global Molnupiravir Sale Price by Type (2019-2024)
2.4 Molnupiravir Segment by Application
2.4.1 Antiviral Drug
2.4.2 COVID-19
2.5 Molnupiravir Sales by Application
2.5.1 Global Molnupiravir Sale Market Share by Application (2019-2024)
2.5.2 Global Molnupiravir Revenue and Market Share by Application (2019-2024)
2.5.3 Global Molnupiravir Sale Price by Application (2019-2024)
3 Global Molnupiravir by Company
3.1 Global Molnupiravir Breakdown Data by Company
3.1.1 Global Molnupiravir Annual Sales by Company (2019-2024)
3.1.2 Global Molnupiravir Sales Market Share by Company (2019-2024)
3.2 Global Molnupiravir Annual Revenue by Company (2019-2024)
3.2.1 Global Molnupiravir Revenue by Company (2019-2024)
3.2.2 Global Molnupiravir Revenue Market Share by Company (2019-2024)
3.3 Global Molnupiravir Sale Price by Company
3.4 Key Manufacturers Molnupiravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molnupiravir Product Location Distribution
3.4.2 Players Molnupiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Molnupiravir by Geographic Region
4.1 World Historic Molnupiravir Market Size by Geographic Region (2019-2024)
4.1.1 Global Molnupiravir Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Molnupiravir Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Molnupiravir Market Size by Country/Region (2019-2024)
4.2.1 Global Molnupiravir Annual Sales by Country/Region (2019-2024)
4.2.2 Global Molnupiravir Annual Revenue by Country/Region (2019-2024)
4.3 Americas Molnupiravir Sales Growth
4.4 APAC Molnupiravir Sales Growth
4.5 Europe Molnupiravir Sales Growth
4.6 Middle East & Africa Molnupiravir Sales Growth
5 Americas
5.1 Americas Molnupiravir Sales by Country
5.1.1 Americas Molnupiravir Sales by Country (2019-2024)
5.1.2 Americas Molnupiravir Revenue by Country (2019-2024)
5.2 Americas Molnupiravir Sales by Type
5.3 Americas Molnupiravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molnupiravir Sales by Region
6.1.1 APAC Molnupiravir Sales by Region (2019-2024)
6.1.2 APAC Molnupiravir Revenue by Region (2019-2024)
6.2 APAC Molnupiravir Sales by Type
6.3 APAC Molnupiravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molnupiravir by Country
7.1.1 Europe Molnupiravir Sales by Country (2019-2024)
7.1.2 Europe Molnupiravir Revenue by Country (2019-2024)
7.2 Europe Molnupiravir Sales by Type
7.3 Europe Molnupiravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molnupiravir by Country
8.1.1 Middle East & Africa Molnupiravir Sales by Country (2019-2024)
8.1.2 Middle East & Africa Molnupiravir Revenue by Country (2019-2024)
8.2 Middle East & Africa Molnupiravir Sales by Type
8.3 Middle East & Africa Molnupiravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molnupiravir
10.3 Manufacturing Process Analysis of Molnupiravir
10.4 Industry Chain Structure of Molnupiravir
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molnupiravir Distributors
11.3 Molnupiravir Customer
12 World Forecast Review for Molnupiravir by Geographic Region
12.1 Global Molnupiravir Market Size Forecast by Region
12.1.1 Global Molnupiravir Forecast by Region (2025-2030)
12.1.2 Global Molnupiravir Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Molnupiravir Forecast by Type
12.7 Global Molnupiravir Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Molnupiravir Product Portfolios and Specifications
13.1.3 Merck Molnupiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Optimus Pharma
13.2.1 Optimus Pharma Company Information
13.2.2 Optimus Pharma Molnupiravir Product Portfolios and Specifications
13.2.3 Optimus Pharma Molnupiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Optimus Pharma Main Business Overview
13.2.5 Optimus Pharma Latest Developments
13.3 Sun Pharma
13.3.1 Sun Pharma Company Information
13.3.2 Sun Pharma Molnupiravir Product Portfolios and Specifications
13.3.3 Sun Pharma Molnupiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sun Pharma Main Business Overview
13.3.5 Sun Pharma Latest Developments
13.4 Beximco
13.4.1 Beximco Company Information
13.4.2 Beximco Molnupiravir Product Portfolios and Specifications
13.4.3 Beximco Molnupiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Beximco Main Business Overview
13.4.5 Beximco Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂